InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
7
T+90 hit rate
100%
T+90 mean return
+44.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Grant Papanek Julie, Director. Director active across 1 company, notably Day One Biopharmaceuticals, Inc.. Aggregated, 9 disclosures have been logged. Breakdown: 0 buy · 7 sells. Total volume traded: €435k. History available since 1 July 2022. The latest transaction was disclosed on 2 September 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
5,000 shares@ US$23.821527.5% of flowCommon StockSEC:0001209191-22-050010:0
4,469 shares@ US$23.209423.9% of flowCommon StockSEC:0001209191-22-048899:0
5,000 shares@ US$20.000822.4% of flowCommon StockSEC:0001209191-22-044898:0
2,600 shares@ US$20.000411.8% of flowCommon StockSEC:0001209191-22-042764:0
1,000 shares@ US$20.004.4% of flowCommon StockSEC:0001209191-22-041994:0
1,242 shares@ US$20.005.6% of flowCommon StockSEC:0001209191-22-041984:0
1,000 shares@ US$20.004.4% of flowCommon StockSEC:0001209191-22-041408:0
7,328,497 sharesCommon StockSEC:0001209191-21-037460
7,328,497 sharesCommon StockSEC:0001209191-21-037460:0
9 of 9 declarations
About Grant Papanek Julie
Julie Grant Papanek is a Director at Day One Biopharmaceuticals, Inc. As a board member, she participates in the governance of the company and the development of its strategy. Day One Biopharmaceuticals is a biopharmaceutical company dedicated to discovering treatments for serious diseases. Julie Grant Papanek brings valuable expertise in the biopharmaceutical sector, enhancing the company's ability to innovate.
